Author

H. Pak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Approach:experimental assay· 1

Frequent Co-Authors

J. Michaux· 3 shared M. Bassani-Sternberg· 3 shared B. J. Stevenson· 2 shared D. Trono· 2 shared E. Planet· 2 shared G. Coukos· 2 shared A. Auger· 1 shared A. Harari· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

J. Michaux

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

KRAB zinc finger proteins ZNF587/ZNF417 protect lymphoma cells from replicative stress-induced inflammation

F. Martins, O. Rosspopoff, J. Carlevaro-Fita, R. Forey, S. Offner, E. Planet, C. Pulver, H. Pak, J. Michaux, M. Bassani-Sternberg, P. Turelli, D. Trono

This study identifies ZNF587 and ZNF417 as pro-oncogenic factors in DLBCL that reduce replicative stress and inflammation, promoting cancer cell survival and immune evasion.

bioRxiv · Mar 8, 2023 · PreprintCancer Biology

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma

M. O. Mohsen, D. E. Speiser, J. Michaux, H. Pak, B. J. Stevenson, M. Vogel, V. P. Inchakalody, S. de Brot, G. Coukos, S. Dermime, M. Bassani-Sternberg, M. F. Bachmann

This paper develops a personalized multi-neoantigen vaccine using long peptides linked to virus-like particles, showing improved anti-tumor effects in a murine mammary carcinoma model.

bioRxiv · Apr 24, 2021Immunology

Integrated Proteogenomic Deep Sequencing and Analytics Accurately Identify Non-Canonical Peptides in Tumor Immunopeptidomes

C. Chong, M. Muller, H. Pak, D. Harnett, F. Huber, D. Grun, M. Leleu, A. Auger, M. Arnaud, B. J. Stevenson, J. Michaux, I. Bilic, A. Hirsekorn, L. Calviello, L. Simo-Riudalbas, , M. Bassani-Sternberg

The paper develops an MS-based proteogenomic approach to identify non-canonical HLA peptides in tumors, finding hundreds of shared and tumor-specific peptides, including an immunogenic one from ABCB5.

bioRxiv · Sep 6, 2019Cancer Biology